Limerston Capital exits Arch Sciences following sale to Element
Limerston Capital has completed its exit of Arch Sciences Group (Arch Sciences), a provider of outsourced analytical solutions to the laboratory research and testing sector, following its sale to Element Materials Technology Group (Element). The sale realised a return for Limerston Capital in excess of 30 per cent IRR. Manchester-headquartered